中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

191 records (took 0.023 seconds)

    New dihydro- and tetrahydro-quinoline compounds, a process for their preparation and pharmaceutical compositions containing them
    72.
    发明专利
    New dihydro- and tetrahydro-quinoline compounds, a process for their preparation and pharmaceutical compositions containing them 未知

    公开(公告)号：AU5600999A

    公开(公告)日：2000-05-04

    申请号：AU5600999

    申请日：1999-10-22

    Applicant: SERVIER LAB

    Inventor： CASARA PATRICK ,  DOREY GILBERT ,  LESTAGE PIERRE ,  LOCKHART BRIAN

    IPC: C07D215/06 ,  A61K31/47 ,  A61K31/497 ,  A61K31/517 ,  A61P9/10 ,  A61P25/00 ,  A61P25/08 ,  A61P25/16 ,  A61P25/28 ,  A61P27/12 ,  A61P43/00 ,  C07D215/20 ,  C07D221/20 ,  C07D401/06 ,  C07D471/10

    Abstract: Dihydro- and tetrahydro-quinoline derivatives (I) are new. Dihydro- and tetrahydro-quinoline derivatives of formula (I) and their acid or base addition salts are new. R1 = H or a group of formula (i); A = H or -B'NZ1Z2; B' = 1-6C alkylene; Z1, Z2 = H, alkyl, 3-8C cycloalkyl or optionally substituted aryl; or NZ1Z2 = heterocycloalkyl or heteroaryl (optionally substituted); R2, R3 = alkyl, 3-8C cycloalkyl, heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, optionally substituted arylalkyl, optionally substituted heteroarylalkyl or aminoalkyl (optionally substituted on N with 1 or 2 alkyl, cycloalkyl, aryl or arylalkyl); or R2 + R3 = form with C of quinoline, 3-8C cycloalkyl or heterocycloalkyl (optionally substituted with alkyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl); R40 = alkyl, 2-6C alkenyl, 2-6C alkynyl (all optionally substituted), H, Q or -V'-Q; V' = 1-6C alkylene, 2-6C alkenylene or 2-6C alkynylene; Q = 3-8C cycloalkyl, aryl, heterocycloalkyl, heteroaryl (all optionally substituted); R5, R41 = H; or R5 + R41 = bond; R6-R9 = H, halo, alkyl, 3-8C cycloalkyl or -OW'; W' = aryl, heteroaryl, arylalkyl, heteroarylalkyl (all optionally substituted), H, alkyl, acyl, 3-8C cycloalkyl or heterocycloalkyl; alkyl = 1-6C; aryl = phenyl, naphthyl or biphenyl; heterocycloalkyl = partially unsaturated 4- to 11-membered mono- or bi-cyclic ring containing 1-6 N, S or O; heteroaryl = aromatic or partially aromatic 4- to 11-membered mono- or bi-cyclic ring containing 1-6 N, S or O; substituted aryl, arylalkyl = aryl or arylalkyl substituted with at least one halo, alkyl, 1-6C alkoxy, 1-6C perhaloalkyl, amino (optionally substituted by 1 or 2 alkyl), CN, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl (optionally substituted with 1 or 2 alkyl on N), nitro or OH; substituted alkyl, alkenyl, alkynyl and cycloalkyl = alkyl, alkenyl, alkynyl and cycloalkyl substituted with at least one OH, 1-6C alkoxy, 1-6C alkylthio, amino (optionally substituted with 1 or 2 alkyl), carboxy, nitro, CN, 1-6C alkoxycarbonyl or aminocarbonyl (optionally substituted with 1 or 2 alkyl on N); substituted heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, heteroarylalkyl = heterocycloalkyl, heterocycloalkylalkyl, heteroaryl, heteroarylalkyl substituted with at least one halo, alkyl, 1-6C alkoxy, 1-6C perhaloalkyl, amino (optionally substituted with 1 or 2 alkyl), CN, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl (optionally substituted with 1 or 2 alkyl on N), nitro, OH or oxo; and provided that R6-R9 are not all H and at least one of R6-R9 is -OW', that R2 and R3 are alkyl when R6-R9 are H, alkyl, alkoxy, R41 and R5 form a bond, R40 is other than H or alkyl; when (I) has one OH and R40 is other than H; when (I) has one methoxy and R40 is other than hydroxyalkyl; and (I) is other than 7-methoxy-2,2-diphenyl-1,2-dihydroquinoline. An Independent claim is also included for the preparation of (I).

    NOUVEAUX DERIVES AZABICYCLIQUES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
    74.
    发明专利
    NOUVEAUX DERIVES AZABICYCLIQUES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT 未知

    公开(公告)号：CA2555216C

    公开(公告)日：2011-10-11

    申请号：CA2555216

    申请日：2005-02-18

    Applicant: SERVIER LAB

    Inventor： CASARA PATRICK ,  CHOLLET ANNE-MARIE ,  DHAINAUT ALAIN ,  BERT LIONEL ,  LESTAGE PIERRE ,  LOCKHART BRIAN

    IPC: C07D209/52 ,  A61K31/403 ,  A61P25/00 ,  C07D403/12

    Abstract: La présente invention concerne les composés de formule (I) : (voir formule I) dans laquelle : .cndot. m et n, identiques ou différents, représentent un entier compris inclusivement entre 0 et 2 avec la somme des deux entiers comprise inclusivement entre 2 et 3, .cndot. p et q, identiques ou différents, représentent un entier compris inclusivement entre 0 et 2, .cndot. Alk représente une chaîne alkylène, alkénylène ou alkynylène, .cndot. X représente un atome d'oxygène, de soufre ou un groupement -N(R)-, avec R représentant un atome d'hydrogène ou un groupement alkyle, .cndot. Y, Y' et W sont tels que définis dans la description, leurs énantiomères, diastéréoisomères, ainsi que leurs sels d'addition à un ou plusieurs acides ou une ou plusieurs bases pharmaceutiquement acceptables. La présente invention concerne également des compositions pharmaceutiques comprenant un composé de formule (I) selon l'invention et leurs utilisations dans le traitement des neuropathologies associées au vieillissement cérébral, des troubles de l'humeur, du comportement alimentaire, du rythme veille-sommeil et du syndrome d'hyperactivité avec déficits attentionnels.

    75.
    发明专利
    未知

    公开(公告)号：BRPI0710443A2

    公开(公告)日：2011-08-16

    申请号：BRPI0710443

    申请日：2007-01-30

    Applicant: SERVIER LAB

    Inventor： GOLDSTEIN SOLO ,  GUILLONNEAU CLAUDE ,  CHARTON YVES ,  LOCKHART BRIAN ,  LESTAGE PIERRE

    IPC: C07D213/65 ,  A61K31/4418 ,  A61P25/00 ,  C07D401/10

    Abstract: Compounds of formula (I): wherein: n represents an integer of from 1 to 6 inclusive, X represents an oxygen atom or an NR6 group, Y represents a carbon atom or a nitrogen atom, Z represents a carbon atom or a nitrogen atom, R1 and R2 represent a hydrogen atom or an alkyl or arylalkyl group, R3 and R4 represent a hydrogen atom or an alkyl group, R5 represents a hydrogen atom or an alkyl, halogen, hydroxy, alkoxy, cyano, nitro, acyl, alkoxycarbonyl, trihaloalkyl, trihaloalkoxy or optionally substituted amino group, R6 represents a hydrogen atom or an alkyl or arylalkyl group, Ra, Rb, Rc, Rd and Re are as defined in the description. Medicinal products containing the same which are useful as specific nicotinic ligands of α4&bgr;2 receptors.

Patent Agency Ranking